AbbVie Inc. Investments, Fair Value Disclosure
AbbVie Inc. (ABBV) had Investments, Fair Value Disclosure of $40.00 million as of 2016-06-30, per its 10-Q filed 2016-08-05.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures
us-gaap:InvestmentsFairValueDisclosure · last filed 2016-08-05
- 2016-06-30: Investments, Fair Value Disclosure $40.00M.
- 2016-03-31: Investments, Fair Value Disclosure $35.00M.
- 2015-12-31: Investments, Fair Value Disclosure $37.00M.
- 2015-09-30: Investments, Fair Value Disclosure $96.00M.
| Period end | Investments, Fair Value Disclosure |
|---|---|
| 2016-06-30 | $40.00M 10-Q · filed 2016-08-05 |
| 2016-03-31 | $35.00M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $37.00M 10-Q · filed 2016-08-05 |
| 2015-09-30 | $96.00M 10-Q · filed 2015-11-06 |
| 2014-12-31 | $145.00M 10-K · filed 2016-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |